Advanced search
Showing results 5501 to 5520 on 6963 in total
-
Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial
Anne-Sophie Michallet, Marie-Sarah Dilhuydy, Fabien Subtil, Valérie Rouillé, Béatrice Mahé, Kamel Laribi, Bruno Villemagne, Gilles Salles, Olivier Tournilhac, Alain Delmer, Christelle Portois, Brigitte Pegourie, Veronique Leblond, Cécile Tomowiak, Sophie de Guibert, Frédérique Orsini, Anne Banos, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, Loic Ysebaert, Caroline Dartigeas, Malgorzata Truchan Graczyk, Jean Vilque, Thérèse Aurran, Florence Cymbalista, Stéphane Leprêtre, Vincent Levy, Florence Nguyen-Khac, Magali Le Garff-Tavernier, Carmen Aanei, Michel Ticchioni, Remi Letestu, Pierre Feugier
-
Taux élevé de réponse complète (RC) avec maladie résiduelle (MRD) indétectable dans la moelle après une stratégie d’épargne de chimiothérapie guidée par la MRD en première ligne de traitement dans la leucémie lymphoïde chronique (LLC)
A.S. Michallet, M.S. Dilhuydy, F. Subtil, V. Rouille, K. Laribi, Bruno Villemagne, Olivier Tournilhac, V. Leblond, A. Delmer, F. Cymbalista, R. Letestu, V. Lévy, F. Nguyen-Khac, S. Lepretre, P. Feugier
-
Unequal intra‐group variance in trajectory classification
Amna Klich, René Ecochard, Fabien Subtil
-
Short-Term Effects of the Prone Positioning Maneuver on Lung and Chest Wall Mechanics in Patients with Acute Respiratory Distress Syndrome
Zakaria Riad, Mehdi Mezidi, Fabien Subtil, Bruno Louis, Claude Guérin
-
A Quadriparametric Model to Describe the Diversity of Waves Applied to Hormonal Data
Saman Abdullah, Thomas Bouchard, Amna Klich, Rene Leiva, Cecilia Pyper, Christophe Genolini, Fabien Subtil, Jean Iwaz, René Ecochard
-
Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group
Yann Guillermin, Charles Herbaux, Fabien Subtil, Thérèse Aurran-Schleinitz, Florence Cymbalista, Remi Letestu, Stéphane Leprêtre, Sandrine Vaudaux, Kamel Laribi, Véronique Leblond, Yasmina Defoi, Raouf Benchikh, Gilles Salles, Pascal Godmer, Henry Jardel, Fréderic Vallais, Pierre Feugier, Frédérique Orsini, Brigitte Pegourié, Vincent Lévy, Anne-Sophie Michallet
-
CopyMean: A new method to predict monotone missing values in longitudinal studies
C. Genolini, A. Lacombe, R. Ecochard, F. Subtil
-
Impact of variability in adherence to HIV antiretroviral therapy on the immunovirological response and mortality
O. Boussari, F. Subtil, C. Genolini, M. Bastard, J. Iwaz, N. Fonton, Jf. Etard, René Ecochard
-
Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial
Pierre-Yves Meunier, Camille Raynaud, Emmanuelle Guimaraes, François Gueyffier, Laurent Letrilliart
-
Implementation of a centralized pharmacovigilance system in academic pan‐European clinical trials: Experience from EU‐Response and conect4children consortia
Catherine Cornu, Anne Donche, Carine Coffre, Amélie Le Gouge, Boulkedid Rym, Isabelle Vaugier, Frédéric Barbot, Alain Leizorovicz, Nadine Juge, Céline Giraud, François Gueyffier, Alexandra Félin, Thibault Mura, Hugues Chevassus, Christine Binquet
-
Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug
N. Eymard, N. Bessonov, V. Volpert, P. Kurbatova, F. Gueyffier, P. Nony
-
Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis
G. Grenet, H. H. Le, T. Bejan-Angoulvant, S. Erpeldinger, R. Boussageon, B. Kassai, P. Moulin, F. Gueyffier, M. Cucherat
-
GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis
G. Grenet, S. Ribault, G. B. Nguyen, F. Glais, A. Metge, T. Linet, B. Kassai-Koupai, C. Cornu, T. Bejan-Angoulvant, S. Erpeldinger, R. Boussageon, A. Gouraud, F. Bonnet, M. Cucherat, P. Moulin, F. Gueyffier
-
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
S. Erpeldinger, M. B. Rehman, C. Berkhout, C. Pigache, Y. Zerbib, F. Regnault, E. Guerin, I. Supper, Catherine Cornu, B. Kassai, F. Gueyffier, R. Boussageon
-
Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial
F. Gueyffier, F. Subtil, T. Bejan-Angoulvant, Y. Zerbib, J. P. Baguet, J. M. Boivin, A. Mercier, G. Leftheriotis, J. P. Gagnol, J. P. Fauvel, C. Giraud, G. Bricca, Delphine Maucort-Boulch, S. Erpeldinger
-
Different treatment benefits were estimated by clinical trials performed in adults compared with those performed in children
Perrine Janiaud, A. Lajoinie, F. Cour-Andlauer, Catherine Cornu, P. Cochat, Michel Cucherat, F. Gueyffier, B. Kassai
-
The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
Laurence Lion-François, François Gueyffier, Catherine Mercier, Daniel Gérard, Vania Herbillon, Isabelle Kemlin, Diana Rodriguez, Tiphanie Ginhoux, Emeline Peyric, Virginie Coutinho, Valentine Bréant, Vincent Des Portes, Stéphane Pinson, Patrick Combemale, Behrouz Kassai
-
L\textquoterighteffet placebo chez l\textquoterightenfant est méconnu et peu étudié
B. Kassai, H. Gheit, R. Boussageon, F. Gueyffier
-
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.
Rémy Boussageon, Irène Supper, Theodora Bejan-Angoulvant, Nadir Kellou, Michel Cucherat, Jean-Pierre Boissel, Behrouz Kassai, Moreau Alain, François Gueyffier, Catherine Cornu
-
Effect of intensive glucose lowering treatment on all cause mortality cardiovascular death and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
R. Boussageon, T. Bejan-Angoulvant, M. Saadatian-Elahi, S. Lafont, C. Bergeonneau, Behrouz Kassai, S. Erpeldinger, Jm. Wright, François Gueyffier, Catherine Cornu